Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

HeartFlow Plaque Analysis. A European Heart Journal – Cardiovascular Imaging study compared the noninvasive Plaque Analysis technology developed by HeartFlow, which uses advanced AI algorithms to evaluate coronary CT angiography (CCTA) images, with coronary plaque assessments achieved by using intravascular ultrasound (IVUS). The REVEALPLAQUE trial included data from 237 patients. Plaque Analysis showed strong correlation and high accuracy when compared with IVUS.

AI-powered coronary plaque assessments show ‘strong agreement’ with IVUS

HeartFlow's noninvasive Plaque Analysis technology, which uses AI to evaluate CCTA images, delivered assessments that mostly lined up with IVUS results. 

May 16, 2024
Atraverse Medical Hotwire radiofrequency (RF) guidewire. Atraverse Medical, a San Diego-based medical device company founded in 2022, designed the guidewire to give physicians as much freedom as possible while treating heart patients. 

Medical device startup gains FDA clearance for new RF guidewire, raises $12.5M

Atraverse Medical, a San Diego-based medical device company founded in 2022, designed the guidewire to give physicians as much freedom as possible while treating heart patients. 

May 16, 2024
Performing CT-derived fractional flow reserve (CT-FFR) before transcatheter aortic valve replacement (TAVR) improves the accuracy of coronary CT angiography (CCTA) and helps limit unneeded invasive coronary angiography (ICA), according to a new study published in JACC: Cardiovascular Interventions. Heartflow

AI-based CAD assessments dramatically improve vascular surgery outcomes

PAD patients evaluated with HeartFlow's noninvasive FFRCT Analysis technology prior to surgery experienced much better outcomes, including a 63% lower risk of all-cause mortality after five years. 

May 14, 2024
Remote ECG access on a smart phone via the Viz.ai Cardio Suite, which enables access to dynamic ECG, echo, MRI, CT images and reports. It also enables automated detection on imaging to alert care teams for STEMI, hypertrophic cardiomyopathy, pulmonary embolism, aortic dissection and abdominal aortic aneurysm, and heart failure.

Cardiology ranked No. 2 among all specialties with 122 FDA-cleared AI models

Only radiology is associated with more FDA-cleared AI algorithms than cardiology, according to new federal data. 

May 14, 2024
JR Finkelmeier PaceMate

PaceMate names former Philips, BioTelemetry leader its new chief commercial officer

JR Finkelmeier has more than 20 years of experience in the healthcare and medical device industries.

May 14, 2024
artificial intelligence robot evaluates healthcare data. Novo Nordisk announced a new collaboration with Valo Health, a healthcare technology company focused on using artificial intelligence (AI) technology to identify new drug treatments for cardiovascular disease (CVD).

Medtronic adds new AI models to its insertable cardiac monitors

The new algorithms are automatically applied in the cloud; patients wearing the devices are not required to take any additional steps.

May 13, 2024
Abbott’s Aveir DR leadless pacemaker, the world’s very first dual-chamber pacing solution of its kind, is associated with a “reliable” performance after six months, according to new data published in Heart Rhythm.[1]

World’s first dual-chamber leadless pacemaker still going strong after 6 months

Abbott’s Aveir DR leadless pacemaker, the first pacing offering of its kind to gain FDA approval, is linked to a consistent electrical performance six months after implant. Researchers tracked data from nearly 400 patients and presented their full findings in Heart Rhythm.

May 10, 2024
money business cash flow dollar. Kingsway Financial Services, a Chicago-based holding company with subsidiaries in several industries, has acquired New Jersey-based Digital Diagnostics Imaging (DDI) for $11 million. The transaction was funded with $5.4 million in cash and $5.6 million in debt financing.

Medical device company raises $87M to study new-look scaffolds for BTK PAD

R3 Vascular also announced that Christopher M. Owens, a veteran of the medical device industry, is its new president and CEO. 

May 9, 2024

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup